Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor - Results of a pilot study

Neurologia Medico-Chirurgica

Volumn 36, Issue 9, 1996, Pages 632-638

  Sawamura, Yutaka ^a   Ikeda, Jun ^a   Ishii, Nobuaki ^a   Kato, Tsutomu ^a   Tada, Mitsuhiro ^a   Abe, Hiroshi ^a   Shirato, Hiroki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

chemotherapy; cisplatin; etoposide; ifosfamide; medulloblastoma; primitive neuroectodermal tumor

Indexed keywords

CISPLATIN; ETOPOSIDE; IFOSFAMIDE;

ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEDULLOBLASTOMA; MULTIMODALITY CANCER THERAPY; NEPHROTOXICITY; NEUROECTODERM TUMOR; OTOTOXICITY; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 0029743569     PISSN: 03872572     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.36.632     Document Type: Article

References (21)

1. Attard-Montalto S, Plowman N, Breatnach F, Saha V, Eden OB: Is there a danger in delaying radiotherapy in child medulloblastoma? Br J Radiol 66: 807-813, 1993
2. Boor R, Gutjahr P: Etoposide treatment in recurrent medulloblastoma. Neuropediatrics 25: 39-41, 1994
3. Caldemeyer KS, Smith RR, Azzarelli B, Boaz JC: Primary central nervous system malignant rhabdoid tumor: CT and MR appearance simulates a primitive neuroectodermal tumor. Pediatr Neurosurg 21: 232-236, 1994
4. Chang CH, Housepian EM, Herbert CJ Jr: An operative staging system and a megavoltage radiotherapy technique for cerebellar medulloblastomas. Radiology 93: 1351-1359, 1969
5. The Committee of Brain Tumor Registry of Japan: 5-Year relative survival rate (1969-1983). Neurol Med Chir (Tokyo) 32: 476-479, 1992
6. Deutsch M: Introduction, in Deutsch M (ed): Management of Childhood Brain Tumors. Boston, Kluwer Academic Publishers, 1990, pp 1-3
7. Duffner PK, Horowitz ME, Krischer JP, Friedmann HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman HS: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328: 1725-1731, 1993
8. Evans AE, Jenkin DT, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL, Hammond GD: The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg 72: 572-582, 1990
9. Gajjar A, Mulhern RK, Heideman RL, Sanford RA, Douglass EC, Kovnar EH, Langston JA, Jenkins JJ, Kun LE: Medulloblastoma in very young children: Outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol 12: 1212-1216, 1994
10. Hanna SL, Langston JW, Parham DM, Douglass EC: Primary malignant rhabdoid tumor of the brain: Clinical, imaging, and pathologic findings. AJNR Am J Neuroradiol 14: 107-115, 1993
11. Johnson DL, McCabe MA, Nicholson HS, Joseph AL, Getson PR, Byrne J, Brasseux C, Packer RJ, Reaman G: Quality of long-term survival in young children with medulloblastoma. J Neurosurg 80: 1004-1010, 1994
12. Kellie SJ, Kovnar EH, Kun LE, Horowitz ME, Heideman RL, Douglass EC, Langston JW, Sanford RA, Jenkins JJ, Fairclough DL, Ogle L: Neuraxis dissemination in pediatric brain tumors. Cancer 69: 1061-1066, 1992
13. Kovnar EH, Kellie SJ, Horowitz ME, Sanford RA, Langston JW, Mulhern RK, Jenkins JJ, Douglass EC, Etcubanas EE, Fairclough DL, Kun LE: Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system. J Clin Oncol 8: 330-336, 1990
14. McIntosh S, Chen M, Sartain PA, Duncan C, Fishburn R, Klatkin EH, Schwartz AD, Venes JL: Adjuvant chemotherapy for medulloblastoma. Cancer 56: 1316-1319, 1985
15. Mosijczuk AD, Nigro MA, Thomas PR, Burger PC, Krischer JP, Morantz RA, Kurdunowicz B, Mulne AF, Towbin RB, Freeman AI: Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study. Cancer 72: 2755-2762, 1993
16. Packer RJ, Siegel KR, Sutton LN, Evans AE, D'Angio G, Rorke LB, Bunin GR, Schut L: Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: A preliminary report. Ann Neurol 24: 503-508, 1988
17. Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D'Angio G, Wechsler-Jentzsch K, Reaman G, Cohen BH, Brace DA, Rorke LB, Molloy P, Ryan J, LaFond D, Evans AE, Schut L: Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81: 690-698, 1994
18. Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA, Rorke LB, Evans AE, Schut L: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74: 433-440, 1991
19. Roberts RO, Lynch CF, Jones MP, Hart MN: Medulloblastoma: A population-based study of 532 cases. J Neuropathol Exp Neurol 50: 134-144, 1991
20. Sexauer CL, Khan A, Burger PC, Krischer JP, van Eys J, Vats T, Ragab AH: Cisplatin in recurrent pediatric brain tumors. A POG phase II study. Cancer 56: 1497-1501, 1985
21. Tait DM, Thornton-Jones H, Bloom HJG, Lemerle J, Morris-Jones P: Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26: 464-469, 1990